Stocks and Investing Stocks and Investing
Mon, February 27, 2023
Sun, February 26, 2023
Sat, February 25, 2023
Fri, February 24, 2023

Ed Arce Reiterated (TVTX) at Strong Buy and Held Target at $40 on, Feb 24th, 2023


Published on 2024-10-28 01:51:57 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Reiterated "Travere Therapeutics, Inc." (TVTX) at Strong Buy and Held Target at $40 on, Feb 24th, 2023.

Ed has made no other calls on TVTX in the last 4 months.



There are 5 other peers that have a rating on TVTX. Out of the 5 peers that are also analyzing TVTX, 1 agrees with Ed's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Alex Thompson of "Stifel" Initiated at Hold and Held Target at $22 on, Wednesday, December 14th, 2022


These are the ratings of the 4 analyists that currently disagree with Ed


  • Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $44 on, Wednesday, February 22nd, 2023
  • Laura Chico of "Wedbush" Upgraded from Hold to Buy and Held Target at $30 on, Tuesday, February 21st, 2023
  • Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $31 on, Tuesday, February 21st, 2023
  • Do Kim of "Piper Sandler" Maintained at Buy with Increased Target to $46 on, Tuesday, February 21st, 2023